Cargando…
Nemiralisib in Patients with an Acute Exacerbation of COPD: Placebo-Controlled, Dose-Ranging Study
BACKGROUND: Management of acute exacerbations of chronic obstructive pulmonary disease (COPD) is sometimes inadequate leading to either prolonged duration and/or an increased risk of recurrent exacerbations in the period following the initial event. OBJECTIVE: To evaluate the safety and efficacy of...
Autores principales: | Fahy, William A, Homayoun-Valiani, Farshid, Cahn, Anthony, Robertson, Jon, Templeton, Alison, Meeraus, Wilhelmine H, Wilson, Robert, Lowings, Mike, Marotti, Miriam, West, Sarah L, Tabberer, Maggie, Hessel, Edith M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8184152/ https://www.ncbi.nlm.nih.gov/pubmed/34113095 http://dx.doi.org/10.2147/COPD.S309320 |
Ejemplares similares
-
Predicting Re-Exacerbation Timing and Understanding Prolonged Exacerbations: An Analysis of Patients with COPD in the ECLIPSE Cohort
por: Meeraus, Wilhelmine H, et al.
Publicado: (2021) -
Terms and Definitions Used to Describe Recurrence, Treatment Failure and Recovery of Acute Exacerbations of COPD: A Systematic Review of Observational Studies
por: Meeraus, Wilhelmine H, et al.
Publicado: (2021) -
Physiologically Based Pharmacokinetic Modelling of Inhaled Nemiralisib: Mechanistic Components for Pulmonary Absorption, Systemic Distribution, and Oral Absorption
por: Miller, Neil A., et al.
Publicado: (2021) -
Patient experience of moderate asthma attacks: qualitative research in the USA and Germany
por: Tabberer, Maggie, et al.
Publicado: (2022) -
Clinical burden of illness among patients with severe eosinophilic COPD
por: Müllerová, Hana, et al.
Publicado: (2019)